ABCL
Price
$2.08
Change
-$0.09 (-4.15%)
Updated
Apr 10, 04:59 PM (EDT)
Capitalization
643.65M
28 days until earnings call
LTRN
Price
$2.95
Change
+$0.01 (+0.34%)
Updated
Apr 10, 04:59 PM (EDT)
Capitalization
32.14M
26 days until earnings call
Ad is loading...

ABCL vs LTRN

Header iconABCL vs LTRN Comparison
Open Charts ABCL vs LTRNBanner chart's image
AbCellera Biologics
Price$2.08
Change-$0.09 (-4.15%)
Volume$72.89K
Capitalization643.65M
Lantern Pharma
Price$2.95
Change+$0.01 (+0.34%)
Volume$100
Capitalization32.14M
ABCL vs LTRN Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. LTRN commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and LTRN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 11, 2025
Stock price -- (ABCL: $2.16 vs. LTRN: $2.98)
Brand notoriety: ABCL and LTRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 127% vs. LTRN: 107%
Market capitalization -- ABCL: $643.65M vs. LTRN: $32.14M
ABCL [@Biotechnology] is valued at $643.65M. LTRN’s [@Biotechnology] market capitalization is $32.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $281.65B to $0. The average market capitalization across the [@Biotechnology] industry is $2.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileLTRN’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • LTRN’s FA Score: 1 green, 4 red.
According to our system of comparison, ABCL is a better buy in the long-term than LTRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while LTRN’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 5 bearish.
  • LTRN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LTRN is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -2.70% price change this week, while LTRN (@Biotechnology) price change was -12.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.53%. For the same industry, the average monthly price growth was -18.05%, and the average quarterly price growth was -19.90%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

LTRN is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (-7.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($644M) has a higher market cap than LTRN($32.1M). LTRN YTD gains are higher at: -6.583 vs. ABCL (-26.280). LTRN has higher annual earnings (EBITDA): -21.18M vs. ABCL (-204.15M). ABCL has more cash in the bank: 626M vs. LTRN (28.1M). LTRN has less debt than ABCL: LTRN (291K) vs ABCL (65.4M). ABCL has higher revenues than LTRN: ABCL (28.8M) vs LTRN (0).
ABCLLTRNABCL / LTRN
Capitalization644M32.1M2,006%
EBITDA-204.15M-21.18M964%
Gain YTD-26.280-6.583399%
P/E RatioN/AN/A-
Revenue28.8M0-
Total Cash626M28.1M2,228%
Total Debt65.4M291K22,474%
TECHNICAL ANALYSIS
Technical Analysis
ABCLLTRN
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 18 days ago
77%
Bullish Trend 18 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TTD54.128.85
+19.55%
Trade Desk (The)
CLSK7.630.89
+13.20%
CleanSpark
ORLA9.280.99
+11.94%
Orla Mining Ltd
AFRI8.750.46
+5.55%
Forafric Global PLC
KZR4.100.08
+1.99%
Kezar Life Sciences Inc

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+11.92%
CRSP - ABCL
58%
Loosely correlated
+11.58%
NTLA - ABCL
57%
Loosely correlated
+12.74%
BEAM - ABCL
56%
Loosely correlated
+12.59%
VCYT - ABCL
56%
Loosely correlated
+12.88%
ABSI - ABCL
54%
Loosely correlated
+13.66%
More

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with ABCL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
+15.50%
ABCL - LTRN
38%
Loosely correlated
+11.92%
SYRE - LTRN
37%
Loosely correlated
+13.14%
CRSP - LTRN
37%
Loosely correlated
+11.58%
ATAI - LTRN
37%
Loosely correlated
+7.44%
INZY - LTRN
36%
Loosely correlated
+6.49%
More